
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Barington/Hilco Acquisition (BHAC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/31/2025: BHAC (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 1.6% | Avg. Invested days 68 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 70.93M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 43 | Beta -0.07 | 52 Weeks Range 2.01 - 13.69 | Updated Date 04/1/2025 |
52 Weeks Range 2.01 - 13.69 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.84 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -17.77% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 83985654 | Price to Sales(TTM) - |
Enterprise Value 83985654 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -58.13 | Shares Outstanding 5312120 | Shares Floating 1212118 |
Shares Outstanding 5312120 | Shares Floating 1212118 | ||
Percent Insiders 77.18 | Percent Institutions 1.82 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Barington/Hilco Acquisition
Company Overview
History and Background
Barington/Hilco Acquisition is not a publicly traded US stock. This query lacks the proper information on its history and background to be provided
Core Business Areas
Leadership and Structure
This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Positioning
This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Total Addressable Market (TAM)
This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Competitive landscape data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Future Projections: Future projection data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Recent Initiatives: Recent initiative data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.
Summary
Barington/Hilco Acquisition is not a publicly traded US stock. Thus, most data required for this analysis cannot be derived. Therefore, an accurate assessment of its overall strength and position within the US stock market cannot be provided based on the current criteria.
Similar Companies
Sources and Disclaimers
Data Sources:
- Publicly available online search results.
Disclaimers:
The analysis is limited by the lack of publicly available information. The AI-based rating is based on incomplete data and should be interpreted with caution.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Barington/Hilco Acquisition
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-30 | CEO & Director Mr. Carl M. Stanton CPA | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website https://www.bh3ac.com |
Full time employees - | Website https://www.bh3ac.com |
Focus Impact BH3 Acquisition Company does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Crixus BH3 Acquisition Company and changed its name to Focus Impact BH3 Acquisition Company in November 2023. Focus Impact BH3 Acquisition Company was incorporated in 2021 and is based in New York, New York. Focus Impact BH3 Acquisition Company operates as subsidiary of Focus Impact BHAC Sponsor, LLC.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.